Zkusit zdarma
Editas Medicine, Inc.

Editas Medicine, Inc.

EDIT
Cena:
$ 2.76
+0.09 (3.37%)
Valuace
70
Růst
30
Zdraví
75
Souhrn Finanční data Pro investory Předpovědi Zprávy Dividendy Zisky Návštěvnost webu Akcionáři
Souhrn
Finanční data
Pro investory
Předpovědi
Zprávy
Dividendy
Zisky
Návštěvnost webu
Akcionáři

Zprávy

Zahraniční články
Tiskové zprávy
Dokumenty ke stáhnutí
Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting

Editas Medicine Reports New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at the American Society of Gene and Cell Therapy 2026 Annual Meeting

6:01 14-05-2026

CAMBRIDGE, Mass. , May 14, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneeri...

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

EDIT's Q1 Loss Narrower Than Expected, Pipeline in Focus

13:01 06-05-2026

Editas narrows Q1 loss as costs fall, but revenues drop sharply. Pipeline focus shifts to in vivo ge...

Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates

Editas Medicine (EDIT) Reports Q1 Loss, Misses Revenue Estimates

9:26 05-05-2026

Editas Medicine (EDIT) came out with a quarterly loss of $0.26 per share versus the Zacks Consensus ...

Editas Medicine Announces First Quarter 2026 Results and Business Updates

Editas Medicine Announces First Quarter 2026 Results and Business Updates

7:00 05-05-2026

EDIT-401, which demonstrated >90% mean LDL-C reduction in preclinical studies, on track to achieve e...

Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences

Editas Medicine to Present New Preclinical Data Demonstrating Progress of EDIT-401 as Potential Treatment for Hyperlipidemia at Upcoming Scientific Conferences

16:31 27-04-2026

CAMBRIDGE, Mass., April 27, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneer...

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

9:56 13-04-2026

The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should tak...

Editas Medicine, Inc. (NASDAQ:EDIT) Receives Average Recommendation of “Moderate Buy” from Analysts

Editas Medicine, Inc. (NASDAQ:EDIT) Receives Average Recommendation of “Moderate Buy” from Analysts

2:18 13-04-2026

Shares of Editas Medicine, Inc. (NASDAQ: EDIT - Get Free Report) have received an average rating of ...

Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?

Editas (EDIT) Up 3.8% Since Last Earnings Report: Can It Continue?

12:31 08-04-2026

Editas (EDIT) reported earnings 30 days ago. What's next for the stock?...

JPMorgan Chase & Co. Has $2.85 Million Position in Editas Medicine, Inc. $EDIT

JPMorgan Chase & Co. Has $2.85 Million Position in Editas Medicine, Inc. $EDIT

4:46 06-04-2026

JPMorgan Chase and Co. cut its holdings in Editas Medicine, Inc. (NASDAQ: EDIT) by 23.0% in the unde...

Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference

Editas Medicine Announces U.S. Patent and Trademark Office Reaffirms its Prior Decision in Favor of the Broad Institute in CRISPR/Cas9 Interference

7:00 27-03-2026

CAMBRIDGE, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneer...

Is Editas Medicine Going to $0?

Is Editas Medicine Going to $0?

17:30 17-03-2026

Editas Medicine has been on fire over the trailing-12-month period. However, the stock has been crus...

Editas Medicine, Inc. (EDIT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

Editas Medicine, Inc. (EDIT) Presents at Barclays 28th Annual Global Healthcare Conference Transcript

10:42 12-03-2026

Editas Medicine, Inc. (EDIT) Presents at Barclays 28th Annual Global Healthcare Conference Transcrip...

EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y

EDIT Stock Up on Narrower-Than-Expected Q4 Loss, Revenues Rise Y/Y

12:11 10-03-2026

Editas stock jumps 16% on reporting a narrower-than-expected Q4 loss and beating revenue estimates w...

Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates

Editas Medicine (EDIT) Reports Q4 Loss, Tops Revenue Estimates

9:15 09-03-2026

Editas Medicine (EDIT) came out with a quarterly loss of $0.06 per share versus the Zacks Consensus ...

Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates

Editas Medicine Announces Fourth Quarter and Full Year 2025 Results and Business Updates

7:00 09-03-2026

Lead candidate, EDIT-401, which demonstrated >90% mean LDL-C reduction in preclinical studies, remai...

Editas Medicine to Participate in Upcoming Investor Conferences

Editas Medicine to Participate in Upcoming Investor Conferences

9:00 23-02-2026

CAMBRIDGE, Mass., Feb. 23, 2026 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a pioneeri...

Top 3 Genomics Stocks to Consider for Your Portfolio

Top 3 Genomics Stocks to Consider for Your Portfolio

9:51 18-11-2025

Genomics gains momentum as EDIT, SANA, and PACB emerge as standout picks amid rapid advances in sequ...

Editas Q3 Loss Narrower Than Expected, Revenues Increase Y/Y

Editas Q3 Loss Narrower Than Expected, Revenues Increase Y/Y

11:41 11-11-2025

EDIT reports narrower Q3 loss, boosts revenues on a Bristol Myers milestone, and advances in vivo ge...

Editas Medicine (EDIT) Reports Q3 Loss, Beats Revenue Estimates

Editas Medicine (EDIT) Reports Q3 Loss, Beats Revenue Estimates

9:25 10-11-2025

Editas Medicine (EDIT) came out with a quarterly loss of $0.28 per share versus the Zacks Consensus ...

Editas Medicine Announces Third Quarter 2025 Results and Business Updates

Editas Medicine Announces Third Quarter 2025 Results and Business Updates

7:00 10-11-2025

In vivo preclinical proof-of-concept data presented at AHA and ESGCT demonstrating >90% LDL-C reduc...

close

GENFLOW BIOSCIENCES PLC ANNOUNCES DIRECTORATE CHANGE

19-01-2026
THE INFORMATION CONTAINED WITHIN THIS ANNOUNCEMENT IS DEEMED BY THE COMPANY TO CONSTITUTE INSIDE INF...
Více zde

EDITAS MEDICINE ANNOUNCES THIRD QUARTER 2025 RESULTS AND BUSINESS UPDATES

10-11-2025
IN VIVO PRECLINICAL PROOF-OF-CONCEPT DATA PRESENTED AT AHA AND ESGCT DEMONSTRATING >90% LDL-C REDUC...
Více zde

EDITAS MEDICINE ANNOUNCES EDIT-401 POSTER PRESENTATION AT THE AMERICAN HEART ASSOCIATION (AHA) SCIENTIFIC SESSIONS 2025

03-11-2025
CAMBRIDGE, MASS., NOV. 03, 2025 (GLOBE NEWSWIRE) -- EDITAS MEDICINE, INC. (NASDAQ: EDIT), A PIONEERI...
Více zde

EDITAS MEDICINE REPORTS IN VIVO PROOF-OF-CONCEPT DATA FOR EDIT-401 AT THE EUROPEAN SOCIETY OF GENE AND CELL THERAPY (ESGCT) 32ND ANNUAL CONGRESS

09-10-2025
PRECLINICAL DATA DEMONSTRATES PROOF-OF-CONCEPT FOR EDIT-401 WITH ≥90% MEAN LDL-C REDUCTION IN NON-...
Více zde

EDITAS MEDICINE ANNOUNCES EDIT-401 ORAL PRESENTATION AT THE EUROPEAN SOCIETY OF GENE AND CELL THERAPY (ESGCT) 32ND ANNUAL CONGRESS AND PARTICIPATION IN UPCOMING INVESTOR CONFERENCES

06-10-2025
CAMBRIDGE, MASS., OCT. 06, 2025 (GLOBE NEWSWIRE) -- EDITAS MEDICINE, INC. (NASDAQ: EDIT), A PIONEERI...
Více zde

EDITAS MEDICINE NOMINATES EDIT-401, AN LDLR-TARGETED MEDICINE, AS LEAD IN VIVO DEVELOPMENT CANDIDATE

02-09-2025
EDIT-401 ACHIEVED ~90% MEAN LDL-C REDUCTION WITH SINGLE DOSE IN NON-HUMAN PRIMATES EDIT-401 ON TRACK...
Více zde

EDITAS MEDICINE TO HOST WEBINAR ANNOUNCING LEAD IN VIVO DEVELOPMENT CANDIDATE

28-08-2025
CAMBRIDGE, MASS., AUG. 28, 2025 (GLOBE NEWSWIRE) -- EDITAS MEDICINE, INC. (NASDAQ: EDIT), A PIONEERI...
Více zde

EDITAS MEDICINE TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

27-08-2025
CAMBRIDGE, MASS., AUG. 27, 2025 (GLOBE NEWSWIRE) -- EDITAS MEDICINE, INC. (NASDAQ: EDIT), A PIONEERI...
Více zde

EDITAS MEDICINE ANNOUNCES SECOND QUARTER 2025 RESULTS AND BUSINESS UPDATES

12-08-2025
COMPANY TO SELECT LEAD DEVELOPMENT CANDIDATE IN SEPTEMBER; ON TRACK TO FILE IND BY MID-2026 AND ACHI...
Více zde

EDITAS MEDICINE REPORTS PROPRIETARY TARGETED LIPID NANOPARTICLE DELIVERY IN NON-HUMAN PRIMATES ENABLES IN VIVO HBG1/2 PROMOTER EDITING FOR SICKLE CELL DISEASE AND BETA THALASSEMIA AT THE EUROPEAN HEMATOLOGY ASSOCIATION 2025 CONGRESS IN JUNE

12-06-2025
ACHIEVED 58% MEAN EDITING AT FIVE MONTHS AFTER A SINGLE DOSE USING HIGH EFFICIENCY HSC DELIVERY, DEM...
Více zde

EDITAS MEDICINE TO PRESENT IN VIVO HSC DELIVERY, EDITING, AND BIODISTRIBUTION DATA AT THE EUROPEAN HEMATOLOGY ASSOCIATION 2025 CONGRESS IN JUNE

14-05-2025
PRECLINICAL STUDIES ACHIEVED THERAPEUTICALLY RELEVANT GENE EDITING LEVELS OF THE HBG1/2 PROMOTER & F...
Více zde

EDITAS MEDICINE REPORTS NEW IN VIVO DATA HIGHLIGHTING THE POTENTIAL OF EDITAS' GENE UPREGULATION STRATEGY IN HSCS AT THE AMERICAN SOCIETY OF GENE AND CELL THERAPY ANNUAL MEETING

14-05-2025
DATA DEMONSTRATE THERAPEUTICALLY RELEVANT EDITING LEVELS USING A CLINICALLY VALIDATED STRATEGY, SUPP...
Více zde

EDITAS MEDICINE REPORTS NEW IN VIVO PROOF OF CONCEPT DATA IN AN UNDISCLOSED LIVER TARGET AT THE AMERICAN SOCIETY OF GENE AND CELL THERAPY ANNUAL MEETING

13-05-2025
IN VIVO CRISPR EDITING RESULTS IN FUNCTIONAL UPREGULATION OF A LIVER TARGET PROTEIN AND MEANINGFUL R...
Více zde

EDITAS MEDICINE ANNOUNCES FIRST QUARTER 2025 RESULTS AND BUSINESS UPDATES

12-05-2025
COMPANY TO SHARE IN VIVO PRECLINICAL DATA DEMONSTRATING THE SUCCESSFUL USE OF TARGETED LIPID NANOPAR...
Více zde

EDITAS MEDICINE ANNOUNCES U.S. COURT OF APPEALS FOR THE FEDERAL CIRCUIT REMANDS CRISPR PATENT INTERFERENCE TO PATENT TRIAL AND APPEAL BOARD

12-05-2025
CAMBRIDGE, MASS., MAY 12, 2025 (GLOBE NEWSWIRE) -- EDITAS MEDICINE, INC. (NASDAQ: EDIT), A PIONEERIN...
Více zde

EDITAS MEDICINE TO ANNOUNCE FIRST QUARTER 2025 FINANCIAL RESULTS AND TO PARTICIPATE IN INVESTOR CONFERENCE IN MAY

05-05-2025
CAMBRIDGE, MASS., MAY 05, 2025 (GLOBE NEWSWIRE) -- EDITAS MEDICINE, INC. (NASDAQ: EDIT), A PIONEERIN...
Více zde

EDITAS MEDICINE TO PRESENT PRECLINICAL DATA DEMONSTRATING PROGRESS IN THE DEVELOPMENT OF AN IN VIVO GENE EDITING PIPELINE AT THE AMERICAN SOCIETY OF GENE AND CELL THERAPY ANNUAL MEETING

28-04-2025
CAMBRIDGE, MASS., APRIL 28, 2025 (GLOBE NEWSWIRE) -- EDITAS MEDICINE, INC. (NASDAQ: EDIT), A PIONEER...
Více zde

EDITAS MEDICINE ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITION

20-03-2025
ERICK J. LUCERA TO STEP DOWN AS CFO TO PURSUE ANOTHER OPPORTUNITY SENIOR VICE PRESIDENT OF FINANCE A...
Více zde

EDITAS MEDICINE ANNOUNCES FOURTH QUARTER AND FULL YEAR 2024 RESULTS AND BUSINESS UPDATES

05-03-2025
ON TRACK TO DECLARE TWO IN VIVO EDITING DEVELOPMENT CANDIDATES VIA GENE UPREGULATION, ONE IN HSCS AN...
Více zde

EDITAS MEDICINE TO ANNOUNCE FOURTH QUARTER/FULL YEAR 2024 FINANCIAL RESULTS AND TO PARTICIPATE IN INVESTOR CONFERENCES IN MARCH

24-02-2025
CAMBRIDGE, MASS., FEB. 24, 2025 (GLOBE NEWSWIRE) -- EDITAS MEDICINE, INC. (NASDAQ: EDIT), A PIONEERI...
Více zde

EDITAS MEDICINE HIGHLIGHTS NEW IN VIVO PRECLINICAL PROOF OF CONCEPT DATA, ANTICIPATED 2025 KEY MILESTONES, AND THREE-YEAR STRATEGIC PRIORITIES

13-01-2025
CAMBRIDGE, MASS., JAN. 13, 2025 (GLOBE NEWSWIRE) -- EDITAS MEDICINE, INC. (NASDAQ: EDIT), A PIONEERI...
Více zde

EDITAS MEDICINE TO PRESENT AT THE 43RD ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

06-01-2025
CAMBRIDGE, MASS., JAN. 06, 2025 (GLOBE NEWSWIRE) -- EDITAS MEDICINE, INC. (NASDAQ: EDIT), A LEADING ...
Více zde

EDITAS MEDICINE ANNOUNCES STRATEGIC TRANSITION TO IN VIVO GENE EDITING COMPANY WITH INTENT TO ACHIEVE HUMAN PROOF OF CONCEPT IN APPROXIMATELY TWO YEARS

12-12-2024
CAMBRIDGE, MASS., DEC. 12, 2024 (GLOBE NEWSWIRE) -- EDITAS MEDICINE, INC. (NASDAQ: EDIT), A LEADING ...
Více zde

EDITAS MEDICINE REPORTS UPDATED CLINICAL DATA FROM THE RUBY TRIAL OF RENI-CEL IN PATIENTS WITH SEVERE SICKLE CELL DISEASE AT THE AMERICAN SOCIETY OF HEMATOLOGY (ASH) ANNUAL MEETING

09-12-2024
POSTER PRESENTATION AT ASH ON MONDAY, DECEMBER 9 AT 6:00 P.M. PT / 9:00 P.M....
Více zde

EDITAS MEDICINE TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

06-11-2024
CAMBRIDGE, MASS., NOV. 06, 2024 (GLOBE NEWSWIRE) -- EDITAS MEDICINE, INC. (NASDAQ: EDIT), A CLINICAL...
Více zde

EDITAS MEDICINE ANNOUNCES THIRD QUARTER 2024 RESULTS AND BUSINESS UPDATES

04-11-2024
ACHIEVED IN VIVO PRECLINICAL PROOF OF CONCEPT OF HBG1/2 EDITING IN HEMATOPOIETIC STEM AND PROGENITOR...
Více zde

EDITAS MEDICINE AND GENEVANT SCIENCES TO COLLABORATE TO DEVELOP NOVEL MRNA-LNP GENE EDITING THERAPEUTICS

21-10-2024
CAMBRIDGE, MASS. AND VANCOUVER, BRITISH COLUMBIA AND BASEL, SWITZERLAND, OCT. 21, 2024 (GLOBE NEWSWI...
Více zde

EDITAS MEDICINE TO HOST STRATEGIC UPDATE WEBINAR TO DETAIL PROGRESS TOWARDS 2024 GOALS, INCLUDING ACHIEVEMENT OF ESTABLISHING IN VIVO PRECLINICAL PROOF OF CONCEPT

18-10-2024
CAMBRIDGE, MASS., OCT. 18, 2024 (GLOBE NEWSWIRE) -- EDITAS MEDICINE, INC. (NASDAQ: EDIT), A CLINICAL...
Více zde

EDITAS MEDICINE ANNOUNCES $50+ MILLION MONETIZATION FINANCING WITH DRI HEALTHCARE TRUST

03-10-2024
STRENGTHENS BALANCE SHEET WITH NON-DILUTIVE CAPITAL TO ENABLE FURTHER PIPELINE DEVELOPMENT AND RELAT...
Více zde

EDITAS MEDICINE TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

28-08-2024
CAMBRIDGE, MASS., AUG. 28, 2024 (GLOBE NEWSWIRE) -- EDITAS MEDICINE, INC. (NASDAQ: EDIT), A CLINICAL...
Více zde

close

Datum Typ Otevřít EDGAR Stáhnout dokument
2025-11-10 00:00:008-KStáhnout
2025-11-10 00:00:0010-QStáhnout
2025-10-09 01:00:008-KStáhnout
2025-10-09 00:00:008-KStáhnout
2025-09-02 01:00:008-KStáhnout
2025-09-02 00:00:008-KStáhnout
2025-08-12 01:00:008-KStáhnout
2025-08-12 01:00:0010-QStáhnout
2025-08-12 00:00:008-KStáhnout
2025-08-12 00:00:0010-QStáhnout
2025-06-12 01:00:008-KStáhnout
2025-06-12 00:00:008-KStáhnout
2025-06-02 01:00:008-KStáhnout
2025-06-02 00:00:008-KStáhnout
2025-05-14 01:00:008-KStáhnout
2025-05-14 00:00:008-KStáhnout
2025-05-13 01:00:008-KStáhnout
2025-05-13 00:00:008-KStáhnout
2025-05-12 01:00:008-KStáhnout
2025-05-12 01:00:0010-QStáhnout
2025-05-12 00:00:008-KStáhnout
2025-05-12 00:00:0010-QStáhnout
2025-03-20 00:00:008-KStáhnout
2025-03-19 23:00:008-KStáhnout
2025-03-05 00:00:008-KStáhnout
2025-03-05 00:00:0010-KStáhnout
2025-03-04 23:00:008-KStáhnout
2025-03-04 23:00:0010-KStáhnout
2025-01-13 00:00:008-KStáhnout
2025-01-12 23:00:008-KStáhnout
2024-12-17 00:00:008-KStáhnout
2024-12-16 23:00:008-KStáhnout
2024-12-12 00:00:008-KStáhnout
2024-12-11 23:00:008-KStáhnout
2024-12-10 00:00:008-KStáhnout
2024-12-09 23:00:008-KStáhnout
2024-11-04 00:00:008-KStáhnout
2024-11-04 00:00:0010-QStáhnout
2024-11-03 23:00:008-KStáhnout
2024-11-03 23:00:0010-QStáhnout
2024-10-22 01:00:008-KStáhnout
2024-10-22 00:00:008-KStáhnout
2024-10-04 01:00:008-KStáhnout
2024-10-04 00:00:008-KStáhnout
2024-08-07 01:00:008-KStáhnout
2024-08-07 01:00:0010-QStáhnout
2024-08-07 00:00:008-KStáhnout
2024-08-07 00:00:0010-QStáhnout
2024-06-27 01:00:008-KStáhnout
2024-06-27 00:00:008-KStáhnout
2024-06-14 01:00:008-KStáhnout
2024-06-14 00:00:008-KStáhnout
2024-05-31 01:00:008-KStáhnout
2024-05-31 00:00:008-KStáhnout
2024-05-08 01:00:008-KStáhnout
2024-05-08 01:00:0010-QStáhnout
2024-05-08 00:00:008-KStáhnout
2024-05-08 00:00:0010-QStáhnout
2024-02-28 00:00:008-KStáhnout
2024-02-28 00:00:0010-KStáhnout
2024-02-27 23:00:008-KStáhnout
2024-02-27 23:00:0010-KStáhnout
2023-12-13 00:00:008-KStáhnout
2023-12-12 23:00:008-KStáhnout
2023-12-11 00:00:008-KStáhnout
2023-12-10 23:00:008-KStáhnout
2023-11-22 00:00:008-KStáhnout
2023-11-21 23:00:008-KStáhnout
2023-11-03 00:00:008-KStáhnout
2023-11-03 00:00:0010-QStáhnout
2023-11-02 23:00:008-KStáhnout
2023-11-02 23:00:0010-QStáhnout
2023-10-10 01:00:008-KStáhnout
2023-10-10 00:00:008-KStáhnout
2023-08-02 01:00:008-KStáhnout
2023-08-02 01:00:0010-QStáhnout
2023-08-02 00:00:008-KStáhnout
2023-08-02 00:00:0010-QStáhnout
2023-06-15 01:00:008-KStáhnout
2023-06-15 00:00:008-KStáhnout
2023-06-09 01:00:008-KStáhnout
2023-06-09 00:00:008-KStáhnout
2023-06-05 01:00:008-KStáhnout
2023-06-05 00:00:008-KStáhnout
2023-05-17 01:00:008-KStáhnout
2023-05-17 00:00:008-KStáhnout
2023-05-05 01:00:008-KStáhnout
2023-05-05 01:00:0010-QStáhnout
2023-05-05 00:00:008-KStáhnout
2023-05-05 00:00:0010-QStáhnout
2023-04-13 01:00:008-KStáhnout
2023-04-13 00:00:008-KStáhnout
2023-03-14 00:00:008-KStáhnout
2023-03-13 23:00:008-KStáhnout
2023-02-22 00:00:008-KStáhnout
2023-02-22 00:00:0010-KStáhnout
2023-02-21 23:00:008-KStáhnout
2023-02-21 23:00:0010-KStáhnout
2023-01-09 00:00:008-KStáhnout
2023-01-08 23:00:008-KStáhnout
2022-12-06 00:00:008-KStáhnout
2022-12-05 23:00:008-KStáhnout
2022-11-17 00:00:008-KStáhnout
2022-11-16 23:00:008-KStáhnout
2022-11-02 00:00:008-KStáhnout
2022-11-02 00:00:0010-QStáhnout
2022-11-01 23:00:008-KStáhnout
2022-11-01 23:00:0010-QStáhnout
2022-08-03 01:00:008-KStáhnout
2022-08-03 01:00:0010-QStáhnout
2022-08-03 00:00:008-KStáhnout
2022-08-03 00:00:0010-QStáhnout
2022-06-13 01:00:008-KStáhnout
2022-06-13 00:00:008-KStáhnout
2022-05-04 01:00:008-KStáhnout
2022-05-04 01:00:0010-QStáhnout
2022-05-04 00:00:008-KStáhnout
2022-05-04 00:00:0010-QStáhnout
2022-04-14 01:00:008-KStáhnout
2022-04-14 00:00:008-KStáhnout
2022-02-24 00:00:008-KStáhnout
2022-02-24 00:00:0010-KStáhnout
2022-02-23 23:00:008-KStáhnout
2022-02-23 23:00:0010-KStáhnout
2022-02-07 00:00:008-KStáhnout
2022-02-06 23:00:008-KStáhnout
2021-11-09 00:00:0010-QStáhnout
2021-11-08 23:00:0010-QStáhnout
2021-11-08 00:00:008-KStáhnout
2021-11-07 23:00:008-KStáhnout
2021-10-28 01:00:008-KStáhnout
2021-10-28 00:00:008-KStáhnout
2021-09-29 01:00:008-KStáhnout
2021-09-29 00:00:008-KStáhnout
2021-09-08 01:00:008-KStáhnout
2021-09-08 00:00:008-KStáhnout
2021-08-05 01:00:0010-QStáhnout
2021-08-05 00:00:0010-QStáhnout
2021-08-04 01:00:008-KStáhnout
2021-08-04 00:00:008-KStáhnout
2021-06-08 01:00:008-KStáhnout
2021-06-08 00:00:008-KStáhnout
2021-05-14 01:00:008-KStáhnout
2021-05-14 00:00:008-KStáhnout
2021-05-06 01:00:0010-QStáhnout
2021-05-06 00:00:0010-QStáhnout
2021-05-05 01:00:008-KStáhnout
2021-05-05 00:00:008-KStáhnout
2021-02-26 00:00:0010-KStáhnout
2021-02-25 23:00:0010-KStáhnout
2021-02-25 00:00:008-KStáhnout
2021-02-24 23:00:008-KStáhnout
2021-02-08 00:00:008-KStáhnout
2021-02-07 23:00:008-KStáhnout
2021-01-21 00:00:008-KStáhnout
2021-01-20 23:00:008-KStáhnout
2021-01-19 00:00:008-KStáhnout
2021-01-18 23:00:008-KStáhnout
2021-01-11 00:00:008-KStáhnout
2021-01-10 23:00:008-KStáhnout
2020-12-18 00:00:008-KStáhnout
2020-12-17 23:00:008-KStáhnout
2020-11-06 00:00:0010-QStáhnout
2020-11-05 23:00:0010-QStáhnout
2020-11-05 00:00:008-KStáhnout
2020-11-04 23:00:008-KStáhnout
2020-08-07 01:00:0010-QStáhnout
2020-08-07 00:00:0010-QStáhnout
2020-08-06 01:00:008-KStáhnout
2020-08-06 00:00:008-KStáhnout
2020-06-25 01:00:008-KStáhnout
2020-06-25 00:00:008-KStáhnout
2020-06-15 01:00:008-KStáhnout
2020-06-15 00:00:008-KStáhnout
2020-05-15 01:00:008-KStáhnout
2020-05-15 00:00:008-KStáhnout
2020-05-08 01:00:0010-QStáhnout
2020-05-08 00:00:0010-QStáhnout
2020-05-07 01:00:008-KStáhnout
2020-05-07 00:00:008-KStáhnout
2020-05-06 01:00:008-KStáhnout
2020-05-06 00:00:008-KStáhnout
2020-02-26 00:00:008-KStáhnout
2020-02-26 00:00:0010-KStáhnout
2020-02-25 23:00:008-KStáhnout
2020-02-25 23:00:0010-KStáhnout
2020-01-10 00:00:008-KStáhnout
2020-01-09 23:00:008-KStáhnout
2019-11-12 00:00:008-KStáhnout
2019-11-12 00:00:0010-QStáhnout
2019-11-11 23:00:008-KStáhnout
2019-11-11 23:00:0010-QStáhnout
2019-09-30 01:00:008-KStáhnout
2019-09-30 00:00:008-KStáhnout
2019-08-07 01:00:0010-QStáhnout
2019-08-07 00:00:0010-QStáhnout
2019-08-06 01:00:008-KStáhnout
2019-08-06 00:00:008-KStáhnout
2019-06-14 01:00:008-KStáhnout
2019-06-14 00:00:008-KStáhnout
2019-05-08 01:00:0010-QStáhnout
2019-05-08 00:00:0010-QStáhnout
2019-05-07 01:00:008-KStáhnout
2019-05-07 00:00:008-KStáhnout
2019-03-01 00:00:0010-KStáhnout
2019-02-28 23:00:0010-KStáhnout
2019-02-28 00:00:008-KStáhnout
2019-02-27 23:00:008-KStáhnout
2019-02-07 00:00:008-KStáhnout
2019-02-06 23:00:008-KStáhnout
2019-01-22 00:00:008-KStáhnout
2019-01-21 23:00:008-KStáhnout
2018-12-21 00:00:008-KStáhnout
2018-12-20 23:00:008-KStáhnout
2018-12-10 00:00:008-KStáhnout
2018-12-09 23:00:008-KStáhnout
2018-11-08 00:00:0010-QStáhnout
2018-11-07 23:00:0010-QStáhnout
2018-11-07 00:00:008-KStáhnout
2018-11-06 23:00:008-KStáhnout
2018-08-07 01:00:0010-QStáhnout
2018-08-07 00:00:0010-QStáhnout
2018-08-06 01:00:008-KStáhnout
2018-08-06 00:00:008-KStáhnout
2018-06-19 01:00:008-KStáhnout
2018-06-19 00:00:008-KStáhnout
2018-06-08 01:00:008-KStáhnout
2018-06-08 00:00:008-KStáhnout
2018-05-04 01:00:0010-QStáhnout
2018-05-04 00:00:0010-QStáhnout
2018-05-03 01:00:008-KStáhnout
2018-05-03 00:00:008-KStáhnout
2018-03-28 01:00:008-KStáhnout
2018-03-28 00:00:008-KStáhnout
2018-03-08 00:00:0010-KStáhnout
2018-03-07 23:00:0010-KStáhnout
2018-03-06 00:00:008-KStáhnout
2018-03-05 23:00:008-KStáhnout
2018-02-16 00:00:008-KStáhnout
2018-02-15 23:00:008-KStáhnout
2018-01-22 00:00:008-KStáhnout
2018-01-21 23:00:008-KStáhnout
2018-01-12 00:00:008-KStáhnout
2018-01-11 23:00:008-KStáhnout
2018-01-04 00:00:008-KStáhnout
2018-01-03 23:00:008-KStáhnout
2017-12-22 00:00:008-KStáhnout
2017-12-21 23:00:008-KStáhnout
2017-12-12 00:00:008-KStáhnout
2017-12-11 23:00:008-KStáhnout
2017-12-07 00:00:008-KStáhnout
2017-12-06 23:00:008-KStáhnout
2017-11-08 00:00:0010-QStáhnout
2017-11-07 23:00:0010-QStáhnout
2017-11-07 00:00:008-KStáhnout
2017-11-06 23:00:008-KStáhnout
2017-09-22 01:00:008-KStáhnout
2017-09-22 00:00:008-KStáhnout
2017-08-09 01:00:008-KStáhnout
2017-08-09 01:00:0010-QStáhnout
2017-08-09 00:00:008-KStáhnout
2017-08-09 00:00:0010-QStáhnout
2017-06-19 01:00:008-KStáhnout
2017-06-19 00:00:008-KStáhnout
2017-05-31 01:00:008-KStáhnout
2017-05-31 00:00:008-KStáhnout
2017-05-15 01:00:008-KStáhnout
2017-05-15 01:00:0010-QStáhnout
2017-05-15 00:00:008-KStáhnout
2017-05-15 00:00:0010-QStáhnout
2017-03-31 01:00:008-KStáhnout
2017-03-31 00:00:008-KStáhnout
2017-03-17 00:00:008-KStáhnout
2017-03-16 23:00:008-KStáhnout
2017-03-15 00:00:008-KStáhnout
2017-03-14 23:00:008-KStáhnout
2017-03-07 00:00:008-KStáhnout
2017-03-06 23:00:008-KStáhnout
2017-03-03 00:00:008-KStáhnout
2017-03-03 00:00:0010-KStáhnout
2017-03-02 23:00:008-KStáhnout
2017-03-02 23:00:0010-KStáhnout
2017-01-23 00:00:008-KStáhnout
2017-01-22 23:00:008-KStáhnout
2016-12-21 00:00:008-KStáhnout
2016-12-20 23:00:008-KStáhnout
2016-11-09 00:00:0010-QStáhnout
2016-11-08 23:00:0010-QStáhnout
2016-11-07 00:00:008-KStáhnout
2016-11-06 23:00:008-KStáhnout
2016-09-02 01:00:008-KStáhnout
2016-09-02 00:00:008-KStáhnout
2016-08-10 01:00:0010-QStáhnout
2016-08-10 00:00:0010-QStáhnout
2016-08-09 01:00:008-KStáhnout
2016-08-09 00:00:008-KStáhnout
2016-08-08 01:00:008-KStáhnout
2016-08-08 00:00:008-KStáhnout
2016-07-29 01:00:008-KStáhnout
2016-07-29 00:00:008-KStáhnout
2016-05-16 01:00:008-KStáhnout
2016-05-16 00:00:008-KStáhnout
2016-05-13 01:00:0010-QStáhnout
2016-05-13 00:00:0010-QStáhnout
2016-04-11 01:00:008-KStáhnout
2016-04-11 00:00:008-KStáhnout
2016-03-30 01:00:008-KStáhnout
2016-03-30 01:00:0010-KStáhnout
2016-03-30 00:00:008-KStáhnout
2016-03-30 00:00:0010-KStáhnout
2016-02-19 00:00:008-KStáhnout
2016-02-18 23:00:008-KStáhnout
2016-02-08 00:00:008-KStáhnout
2016-02-07 23:00:008-KStáhnout
preloader